InHANSE Institute of Head and Neck Studies and Education Contact Us

Name:       Hisham Mehanna

Job title:    Director InHANSE


What I do: 
I am the Chair of Head and Neck Surgery and the Director of the Institute of Head and Neck Studies and Education (InHANSE) at the Institute of Cancer and Genomic Sciences.  I am a head and neck and thyroid surgeon with clinical interests in microvascular reconstructive surgery and endoscopic thyroid and parathyroid surgery.  I have a keen interest in clinical research, especially in clinical trials evaluating the efficacy and effectiveness of new interventions, therapeutic agents and biomarkers in head and neck and thyroid cancer.  I run a research team of 15 researchers and hold over £15m in grants from the Health Technology Assessment Unit, NIHR, Cancer Research UK, Macmillan Cancer Research and industry. 

I am the President of the Head and Neck International Group, and a past President of the British Association of Head Neck Oncologists (BAHNO), and the past Chair of the UK’s National Cancer Research Institute’s head and neck group, responsible for all head neck cancer research in the UK.

I started my medical education in Kuwait, graduating with honours in Basic Medical Sciences in 1990.  I continued my clinical undergraduate education at the University of Glasgow and the West of Scotland, graduating with honours in 1994. I undertook general and ENT surgery specialty training in Glasgow, UK. In 2003, I undertook a fellowship in advanced head and neck and thyroid surgery with Prof Randall Morton, at the Auckland Regional Head and Neck Unit in New Zealand. I received my PhD from the University of Erasmus, Rotterdam. I hold Royal College Fellowships in General Surgery and Otolaryngology-Head Neck Surgery and am on the Specialist Register in the UK.

I started consultant clinical practice in 2004 at University Hospitals Coventry and Warwickshire.   I now practice at University Hospitals Birmingham.

Research Interests
Human papiloma virus positive head and neck cancer, thyroid cancer, clinical trials, drug redeployment. 

Clinical Interests
Oral cancer, thyroid cancer, head and neck microvascular reconstruction, minimally invasive thyroid and parathyroid surgery.


Famous for:
Sending emails and voice mail messages at 3 am

Common remark:
"Let's do it"








Charity appeal

Find out more about our £1m Charity appeal for the AcceleraTED cancer Treatment programme.